|
CHEMBL3837
|
P07711
|
Cathepsin L |
99.74%
|
96.61%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
99.49%
|
97.25%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.21%
|
98.95%
|
|
CHEMBL299
|
P17252
|
Protein kinase C alpha |
99.19%
|
98.03%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
99.06%
|
96.09%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
98.62%
|
93.56%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
98.39%
|
94.45%
|
|
CHEMBL2955
|
O95136
|
Sphingosine 1-phosphate receptor Edg-5 |
98.02%
|
92.86%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
97.59%
|
92.38%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
97.24%
|
98.94%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
97.22%
|
98.33%
|
|
CHEMBL4026
|
P40763
|
Signal transducer and activator of transcription 3 |
97.20%
|
82.69%
|
|
CHEMBL4793
|
Q86TI2
|
Dipeptidyl peptidase IX |
97.13%
|
96.95%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
96.84%
|
96.47%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
96.57%
|
90.17%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
96.48%
|
97.21%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
96.45%
|
100.00%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
96.39%
|
99.17%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
95.76%
|
95.71%
|
|
CHEMBL3892
|
Q99500
|
Sphingosine 1-phosphate receptor Edg-3 |
95.18%
|
97.29%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
95.17%
|
100.00%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
94.85%
|
97.47%
|
|
CHEMBL2996
|
Q05655
|
Protein kinase C delta |
94.85%
|
97.79%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
93.89%
|
97.23%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
92.92%
|
90.71%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
92.83%
|
97.50%
|
|
CHEMBL2815
|
P04629
|
Nerve growth factor receptor Trk-A |
92.56%
|
87.16%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
92.26%
|
94.66%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
92.13%
|
100.00%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
91.83%
|
96.85%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
91.78%
|
94.00%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
91.72%
|
97.09%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
91.61%
|
91.81%
|
|
CHEMBL5979
|
P05186
|
Alkaline phosphatase, tissue-nonspecific isozyme |
90.97%
|
85.40%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
90.46%
|
100.00%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
90.06%
|
97.14%
|
|
CHEMBL3776
|
Q14790
|
Caspase-8 |
89.89%
|
97.06%
|
|
CHEMBL335
|
P18031
|
Protein-tyrosine phosphatase 1B |
89.89%
|
95.17%
|
|
CHEMBL3238
|
P23786
|
Carnitine palmitoyltransferase 2 |
89.78%
|
94.05%
|
|
CHEMBL5163
|
Q9NY46
|
Sodium channel protein type III alpha subunit |
89.76%
|
96.90%
|
|
CHEMBL1907605
|
P24864
|
Cyclin-dependent kinase 2/cyclin E1 |
89.66%
|
92.88%
|
|
CHEMBL4462
|
Q8IXJ6
|
NAD-dependent deacetylase sirtuin 2 |
89.54%
|
90.24%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
89.38%
|
97.50%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
89.30%
|
96.28%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
89.16%
|
93.00%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
88.70%
|
94.33%
|
|
CHEMBL1744525
|
P43490
|
Nicotinamide phosphoribosyltransferase |
88.67%
|
96.25%
|
|
CHEMBL2007625
|
O75874
|
Isocitrate dehydrogenase [NADP] cytoplasmic |
88.63%
|
99.00%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
88.43%
|
91.19%
|
|
CHEMBL230
|
P35354
|
Cyclooxygenase-2 |
88.07%
|
89.63%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
87.65%
|
98.24%
|
|
CHEMBL3145
|
P42338
|
PI3-kinase p110-beta subunit |
86.79%
|
98.75%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
86.57%
|
96.67%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
86.40%
|
97.29%
|
|
CHEMBL3018
|
Q9Y5Y6
|
Matriptase |
86.18%
|
98.33%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
85.37%
|
97.64%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
85.31%
|
98.89%
|
|
CHEMBL5608
|
Q16288
|
NT-3 growth factor receptor |
85.24%
|
95.89%
|
|
CHEMBL4769
|
O95749
|
Geranylgeranyl pyrophosphate synthetase |
84.95%
|
92.08%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
84.81%
|
95.38%
|
|
CHEMBL2001
|
Q9H244
|
Purinergic receptor P2Y12 |
84.67%
|
96.00%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
84.36%
|
97.50%
|
|
CHEMBL5103
|
Q969S8
|
Histone deacetylase 10 |
84.31%
|
90.08%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
83.49%
|
98.10%
|
|
CHEMBL268
|
P43235
|
Cathepsin K |
83.42%
|
96.85%
|
|
CHEMBL3230
|
O95977
|
Sphingosine 1-phosphate receptor Edg-6 |
82.91%
|
94.01%
|
|
CHEMBL1907589
|
P17787
|
Neuronal acetylcholine receptor; alpha4/beta2 |
82.73%
|
94.55%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
82.69%
|
95.89%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
82.50%
|
88.42%
|
|
CHEMBL3976
|
Q9UHL4
|
Dipeptidyl peptidase II |
82.16%
|
92.29%
|
|
CHEMBL1293267
|
Q9HC97
|
G-protein coupled receptor 35 |
82.15%
|
89.34%
|
|
CHEMBL4506
|
Q96EB6
|
NAD-dependent deacetylase sirtuin 1 |
82.15%
|
88.33%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
81.95%
|
91.11%
|
|
CHEMBL4660
|
P28907
|
Lymphocyte differentiation antigen CD38 |
81.95%
|
95.27%
|
|
CHEMBL4303
|
P08238
|
Heat shock protein HSP 90-beta |
81.79%
|
96.77%
|
|
CHEMBL4015
|
P41597
|
C-C chemokine receptor type 2 |
81.44%
|
98.57%
|
|
CHEMBL2534
|
O15530
|
3-phosphoinositide dependent protein kinase-1 |
81.26%
|
95.36%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
81.15%
|
96.00%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
81.14%
|
89.50%
|
|
CHEMBL2431
|
P31751
|
Serine/threonine-protein kinase AKT2 |
80.87%
|
98.33%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
80.14%
|
96.03%
|